Kobayashi Pharmaceutical Stock
Kobayashi Pharmaceutical Stock price
Key metrics
Is Kobayashi Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
Kobayashi Pharmaceutical Stock Analysis
Analyst Opinions
12 Analysts have issued a Kobayashi Pharmaceutical forecast:
Analyst Opinions
12 Analysts have issued a Kobayashi Pharmaceutical forecast:
Financial data from Kobayashi Pharmaceutical
| Mar '25 |
+/-
%
|
||
| Revenue | 161,722 161,722 |
8%
8%
|
|
| Gross Profit | 83,335 83,335 |
15%
15%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 22,367 22,367 |
13%
13%
|
| Net Profit | 10,715 10,715 |
39%
39%
|
|
In millions JPY.
Don't miss a Thing! We will send you all news about Kobayashi Pharmaceutical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
| Head office | Japan |
| CEO | Norikaz Toyoda |
| Employees | 3,615 |
| Founded | 1886 |
| Website | www.kobayashi.co.jp |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
